Between advanced CKD and end-stage kidney disease (ESKD), PTH levels typically rise from moderately elevated to progressively approaching the target ranges commonly applied in dialysis (2–9 times the upper limit of normal [ULN]). The gene discussed is PTH; the disease is chronic kidney disease.